Expression and clinical significance of galetin-3 and EGFR proteins in esophageal squamous carcinoma
10.3760/cma.j.issn.1673-422X.2011.08.023
- VernacularTitle:galetin-3和EGFR蛋白在食管鳞状细胞癌中的表达及临床意义
- Author:
Huaping GU
;
Peizhong SHANG
- Publication Type:Journal Article
- Keywords:
Esophageal neoplasms;
Carcinoma,squamous cell;
Receptor,epidermal growth factor;
Galectin-3
- From:
Journal of International Oncology
2011;38(8):630-632
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo explore the correlation of expression of galetin-3 (Gal-3) and epidermal growth factor receptor (EGFR) with the biological behaviors in esophageal squamous carcinoma(ESC). MethodsImmunohistochemical method was used to examine the expression of Gal-3 and EGFR in 80 specimens of ESC. ResultsThe positive rates of Gal-3 and EGFR was 73.8% (59/80)and 56. 3% (45/80)respectively. The positive rates of Gal-3 and EGFR expression in the patients with poor differentiation, deep infiltration and lymph node metastasis was significantly higher than those with well differentiation, shallow infiltration and without lymph node metastasis ( P < 0. 05 ). The high expression of Gal-3 and EGFR was correlated with higher percentage of death and lower survival rate ( P < 0.05 ). ConclusionThe abnormal expression of Gal-3 and EGFR is closely related with the pathological biology behaviors of ESC. Gal-3 and EGFR can be regarded as objective indicators for forecasting metastasic potential of ESC and estimating prognosis of patients with ESC.